PHARMACY PROJECTS & DOCUMENTS
Detailed process maps are being undertaken with the Pharmacy teams at the WGH, RGH, SJH and RIE. The anticipated benefits from improvement opportunities identified are:
Reduction in the number of sites undertaking overlabelling and associated staff time released to clinical areas for direct patient pharmaceutical care
Rationalisation and agreement of the number of product lines and variations produced
Increase in batch production size and reduction in the frequency of batch productions for same line
Optimal stock holding and turn over
Reduction in the number of labelling errors
Any associated financial benefits from the above